Alexis Demopoulos1, Lisa M DeAngelis. 1. Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Abstract
PURPOSE OF REVIEW: As treatment of the leukemias improves, patients are surviving longer. Recognizing and rapidly treating metastatic complications or avoiding neurotoxic therapies improves outcome, reduces morbidity and mortality, and limits long-term sequelae. RECENT FINDINGS: Neurologic dysfunction may result from leukemic infiltration of the nervous system or as a consequence of chemotherapy or prophylactic craniospinal irradiation. The present review summarizes common problems in the neurologic complications of leukemia and discusses recent advancements in their diagnosis and treatment. SUMMARY: Topics covered in detail include central nervous system prophylaxis, leptomeningeal metastasis, and common hematologic complications affecting the brain. The findings aid in the clinical management of patients with leukemia. Copyright 2002 Lippincott Williams & Wilkins
PURPOSE OF REVIEW: As treatment of the leukemias improves, patients are surviving longer. Recognizing and rapidly treating metastatic complications or avoiding neurotoxic therapies improves outcome, reduces morbidity and mortality, and limits long-term sequelae. RECENT FINDINGS:Neurologic dysfunction may result from leukemic infiltration of the nervous system or as a consequence of chemotherapy or prophylactic craniospinal irradiation. The present review summarizes common problems in the neurologic complications of leukemia and discusses recent advancements in their diagnosis and treatment. SUMMARY: Topics covered in detail include central nervous system prophylaxis, leptomeningeal metastasis, and common hematologic complications affecting the brain. The findings aid in the clinical management of patients with leukemia. Copyright 2002 Lippincott Williams & Wilkins
Authors: Gordon R Macpherson; Charlotte A Hanson; Delores M Thompson; Christine M Perella; Joan L Cmarik; Sandra K Ruscetti Journal: Leuk Res Date: 2011-09-15 Impact factor: 3.156
Authors: A T Burshina; Rajasekar Thirugnanam; Arul Selvan; C Seetharaman; Mani Karthik Kumar; Sangita S Mehta; Virna M Shah Journal: Am J Ophthalmol Case Rep Date: 2020-09-17
Authors: Sujeetha A Rajakumar; Ildiko Grandal; Mark D Minden; Johann K Hitzler; Cynthia J Guidos; Jayne S Danska Journal: Cell Rep Med Date: 2021-12-21